Skip to main content
. 2013 Aug 13;109(6):1476–1481. doi: 10.1038/bjc.2013.472

Table 2. Baseline characteristics and sites of disease according to BSLD.

Variable BSLD ⩽7.5 cm n (%) BSLD >7.5 cm n (%)
Sex
Female 179 (47) 162 (43)
Male
204 (53)
214 (57)
Age (years)
<70 300 (78) 279 (74)
⩾70
83 (22)
97 (26)
Race
White 329 (86) 327 (87)
Black 15 (4) 24 (6)
Other
39 (10)
25 (7)
Stage
IIIB (malignant effusion) 59 (15) 20 (5)
IV/Recurrent
324 (85)
356 (95)
ECOG performance status
0 152 (40) 152 (41)
1
228 (60)
223 (59)
Histology
Adenocarcinoma 277 (73) 237 (63)
Other
105 (27)
138 (37)
Ipsilateral lung
Yes 163 (43) 185 (49)
No
220 (57)
191 (51)
Contralateral lung
Yes 110 (29) 148 (39)
No
273 (71)
228 (61)
Hilar nodes
Yes 131 (34) 185 (49)
No
252 (66)
191 (51)
Mediastinal nodes
Yes 176 (46) 237 (63)
No
207 (54)
139 (37)
Supraclavicular/scalene nodes
Yes 24 (6) 45 (12)
No
359 (94)
331(88)
Pleura
Yes 107 (28) 83 (22)
No
276 (72)
293 (78)
Bone
Yes 130 (34) 106 (28)
No
253 (66)
270 (72)
Liver
Yes 47 (12) 104 (28)
No
336 (88)
272 (72)
Adrenal
Yes 45 (12) 76 (20)
No 338 (88) 300 (80)

Abbreviations: BSLD=baseline sum longest diameter; ECOG=Eastern Cooperative Oncology Group.